Results 131 to 140 of about 15,747 (260)

The Temporomandibular Joint Compromise (TMJC) as a Cause of Otoneurological Symptoms: Headaches, Dizziness and Tinnitus. [PDF]

Int Arch Otorhinolaryngol
Casañas R, González-Esmorís I, Cabrera J, Pérez-Candela V, Saavedra P, Larena-Avellaneda J.   +5 more
europepmc   +1 more source

Environmental Legitimation in A Global Context: Emerging Market Multinational Enterprises Versus Developed Market Multinational Enterprises

Business Ethics, the Environment &Responsibility, EarlyView.
ABSTRACT The purpose of this paper is to study the differences and similarities between emerging market multinationals (EMNEs) and developed market multinationals (DMNEs) in their levels of adoption of environmental management policies and environmental disclosure practices when they increase their international diversification.
Nuria Esther Hurtado‐Torres, Eulogio Cordón‐Pozo, Efrén Gómez‐Bolaños, Maria Ruiz‐Castillo   +3 more
wiley   +1 more source

Towards clean air and health for all in the Andes. [PDF]

Lancet Reg Health Am
Jaramillo-Aguilar DS, Hartinger S, Iglesias V, Steenland K, Rojas-Roa NY, Soria F, Endara-Mina J, Simbaña-Rivera K.   +7 more
europepmc   +1 more source

Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era

British Journal of Haematology, EarlyView.
Summary Data on real‐world survival and treatment patterns in large, unselected myelofibrosis (MF) cohorts remain limited. We analysed 1649 patients with MF diagnosed from 2010 onwards and included in the Spanish Myelofibrosis Registry across 64 centres. Janus kinase (JAK) inhibitors were administered to approximately half of the patients.
Juan‐Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo, Manuel Pérez‐Encinas, José‐María Raya, María‐Teresa Gómez‐Casares, Francisca Ferrer‐Marín, Alberto Hernández‐Sánchez, María‐Laura Fox, Anna Angona, Beatriz Cuevas, María‐Isabel Mata‐Vázquez, Rosa Ayala, Natalia de las Heras, Elvira Mora, Valentín García‐Gutiérrez, Alicia Senín, Jasson Villarreal, Blanca Xicoy, Raúl Pérez‐López, María García‐Fortes, Sonia González de Villambrosia, Elena Magro, María‐José Ramírez, Paula Gómez, Angel Ramírez‐Payer, Clara Martínez‐Valverde, Lucía Pérez‐Lamas, Carmen García‐Hernández, Mercedes Gasior, Luis‐Miguel Juárez‐Salcedo, Francisco Ibáñez, María‐Luisa Antelo, Lucía Guerrero, Alberto Alvarez‐Larrán, Arturo Pereira, on behalf of the Spanish MPN Group (GEMFIN)   +35 more
wiley   +1 more source

Maitland mobilisation improves all ranges of motion in non-traumatic shoulder injury: A randomised controlled trial. [PDF]

S Afr J Physiother
Lalwani-Mangtani KC, Ramos-Luzardo Á, Chirino R, Saavedra P, Fernández-Valerón P.   +4 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

STRATUM-OS: first step in the development and validation of the STRATUM tool based on multimodal data processing to assist surgery in patients affected by intra-axial brain tumours - observational study protocol. [PDF]

BMJ Open
Fabelo H, Ramallo-Fariña Y, Morera J, Piñeiro JF, Lagares A, Jiménez-Roldán L, Burström G, García-Bello MA, García-Pérez L, Falero R, González M, Duque S, Rodriguez-Jimenez C, Hernández M, Delgado-Sánchez JJ, Paredes AB, Hernández G, Ponce P, León R, González-Martín JM, Rodríguez-Esparragón F, Callicó GM, Wägner AM, Clavo B, STRATUM Consortium.   +24 more
europepmc   +1 more source

The nitty‐gritty of vascular permeability in cancer: targeting blood endothelium to control metastases

British Journal of Pharmacology, EarlyView.
Blood vascular permeability is a hallmark of cancer and acts as an active driver of metastatic dissemination. Metastasis accounts for the vast majority of cancer deaths, yet most work has focussed on tumour‐intrinsic traits and angiogenesis, while the specific contribution of endothelial barrier regulation to intravasation and extravasation remains ...
Pierre Boucher, Mérone Da Costa Oliveira, Adrien Levesque, Alexandre Rutault, Patrick Savoyaud, Nicolas Bréchot, Stéphane Germain   +6 more
wiley   +1 more source

Unintended evolutionary consequences of a minimum landing size regulations: Evidence and implications of fisheries-induced evolution. [PDF]

PLoS One
Guerra-Marrero A, Baixauli-Rodríguez J, Espino-Ruano A, Jiménez-Alvarado D, Couce-Montero L, Santana-Del Pino Á, Castro JJ.   +6 more
europepmc   +1 more source

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

British Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli, Cristina Madaudo, Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna   +4 more
wiley   +1 more source